MedPath

THYROGEN

THYROGEN

Approved
DIN Number

02246016

Drug Class

Human

Market Date

Aug 12, 2002

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02246016
AIG Number0147561001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
H01AB01 THYROTROPHIN ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
AHFS Classification68:36.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

THYROTROPIN ALFAActive
Strength: 0.9 MG / VIAL
Monograph: THYROTROPIN ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.